다우존스 지수

무료로 등록하여 실시간 주식 시세, 대화형 차트, 실시간 옵션 플로우 등을 받아보세요.

등록

홈
인베스팅
주식
미국
NASDAQ
bioAffinity Technologies Inc (BIAF)
bioAffinity Technologies Inc (BIAF) 뉴스

BIAF

bioAffinity Technologies (BIAF)

bioAffinity Technologies Inc

일자:

규정 관련뉴스

텍스트 검색:

정렬 기준:

규정 외 뉴스

검색 관련기사 보기:NASDAQ:BIAF

1 2 3 4 5 6 다음 >>

일자	시간	출처	헤드라인	심볼	기업
2025/03/31	22:28	Business Wire	bioAffinity Technologies Reports Record $9.4 Million Revenue for 2024	NASDAQ:BIAF	bioAffinity Technologies Inc
2025/03/26	22:00	Business Wire	Case Study: bioAffinity Technologies’ CyPath® Lung Detects Second Primary Lung Cancer in Patient With History of Lung Cancer	NASDAQ:BIAF	bioAffinity Technologies Inc
2025/03/19	22:00	Business Wire	Case Study: bioAffinity Technologies’ Positive CyPath® Lung Result Leads to Detecting Breast Cancer Recurrence	NASDAQ:BIAF	bioAffinity Technologies Inc
2025/02/27	02:10	PR Newswire (US)	WallachBeth Capital Announces Closing of bioAffinity Technologies Warrant Inducement Transaction for Aggregate Gross Proceeds of $1.4 Million	NASDAQ:BIAF	bioAffinity Technologies Inc
2025/02/27	01:30	Business Wire	bioAffinity Technologies Announces Closing of Warrant Inducement Transaction for Aggregate Gross Proceeds of $1.4 Million	NASDAQ:BIAF	bioAffinity Technologies Inc
2025/02/26	01:05	PR Newswire (US)	WallachBeth Capital Announces bioAffinity Technologies Warrant Inducement for Aggregate Gross Proceeds of $1.4 Million	NASDAQ:BIAF	bioAffinity Technologies Inc
2025/02/25	23:58	Business Wire	bioAffinity Technologies Announces Warrant Inducement for Aggregate Gross Proceeds of $1.4 Million	NASDAQ:BIAF	bioAffinity Technologies Inc
2025/01/22	22:00	Business Wire	bioAffinity Technologies Announces Acceptance of Patent Application for Early-Stage Lung Cancer Diagnostic	NASDAQ:BIAF	bioAffinity Technologies Inc
2025/01/13	22:00	Business Wire	bioAffinity Technologies Reports Positive Results from Texas Beta Launch of CyPath® Lung	NASDAQ:BIAF	bioAffinity Technologies Inc
2024/12/17	22:00	Business Wire	Join bioAffinity Technologies’ Exclusive Live Investor Webinar and Q&A Session on Thursday, December 19	NASDAQ:BIAF	bioAffinity Technologies Inc
2024/12/12	22:00	Business Wire	bioAffinity Technologies Set for Continued Expansion in 2025	NASDAQ:BIAF	bioAffinity Technologies Inc
2024/12/05	22:00	Business Wire	Veterans’ Research Foundation Spotlights CyPath® Lung’s Addition to the Federal Supply Schedule	NASDAQ:BIAF	bioAffinity Technologies Inc
2024/11/14	22:00	Business Wire	bioAffinity Technologies Reports $2.4 Million Revenue for Q3 2024	NASDAQ:BIAF	bioAffinity Technologies Inc
2024/11/04	22:00	Business Wire	bioAffinity Technologies Appoints New Chief Science Officer to Spearhead Product Development	NASDAQ:BIAF	bioAffinity Technologies Inc
2024/10/30	21:00	Business Wire	bioAffinity Technologies Announces Award of Japanese Patent for CyPath® Lung	NASDAQ:BIAF	bioAffinity Technologies Inc
2024/10/22	00:39	PR Newswire (US)	WallachBeth Capital Announces Closing of bioAffinity Technologies $2.6 Million Registered Direct Offering & Concurrent Private Placement	NASDAQ:BIAF	bioAffinity Technologies Inc
2024/10/21	23:45	Business Wire	bioAffinity Technologies Announces Closing of $2.6 Million Registered Direct Offering & Concurrent Private Placement	NASDAQ:BIAF	bioAffinity Technologies Inc
2024/10/19	03:57	PR Newswire (US)	WallachBeth Capital Announces Pricing of bioAffinity Technologies $2.66 Million Registered Direct Offering & Concurrent Private Placement	NASDAQ:BIAF	bioAffinity Technologies Inc
2024/10/19	01:45	Business Wire	bioAffinity Technologies Announces Pricing of $2.66 Million Registered Direct Offering & Concurrent Private Placement	NASDAQ:BIAF	bioAffinity Technologies Inc
2024/10/16	21:00	Business Wire	bioAffinity’s CyPath® Lung Cancer Test Supported by Newly Published Flow Cytometry Guidelines	NASDAQ:BIAF	bioAffinity Technologies Inc
2024/10/10	21:00	Business Wire	bioAffinity Technologies Names J. Michael Edwards as Chief Financial Officer	NASDAQ:BIAF	bioAffinity Technologies Inc
2024/10/09	21:00	Business Wire	bioAffinity Technologies Awarded U.S. Federal Supply Schedule Contract for CyPath® Lung Test	NASDAQ:BIAF	bioAffinity Technologies Inc
2024/09/18	21:00	Business Wire	Peer-Reviewed Study: bioAffinity Technologies’ CyPath® Lung Test Shows Potential Significant Healthcare Savings by Reducing Unnecessary Follow-Up, Medical Complications and Overdiagnosis	NASDAQ:BIAF	bioAffinity Technologies Inc
2024/08/26	21:58	IH Market News	IBM Closes China Research Division, Uber Fined $324M, Starliner to Return Without Astronauts	NASDAQ:BIAF	bioAffinity Technologies Inc
2024/08/24	06:17	Edgar (US Regulatory)	Form PRE 14A - Other preliminary proxy statements	NASDAQ:BIAF	bioAffinity Technologies Inc
2024/08/24	06:15	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:BIAF	bioAffinity Technologies Inc
2024/08/24	06:15	Business Wire	bioAffinity Technologies CFO to Depart for New Opportunity; J. Michael Edwards to Return as Interim CFO	NASDAQ:BIAF	bioAffinity Technologies Inc
2024/08/15	05:19	Edgar (US Regulatory)	Form 424B3 - Prospectus [Rule 424(b)(3)]	NASDAQ:BIAF	bioAffinity Technologies Inc
2024/08/15	05:19	Edgar (US Regulatory)	Form 424B3 - Prospectus [Rule 424(b)(3)]	NASDAQ:BIAF	bioAffinity Technologies Inc
2024/08/14	22:37	Edgar (US Regulatory)	Form 10-Q - Quarterly report [Sections 13 or 15(d)]	NASDAQ:BIAF	bioAffinity Technologies Inc

검색 관련기사 보기:NASDAQ:BIAF

1 2 3 4 5 6 다음 >>

Global X Millennial Cons...

RouteMaster Capital

USA Real Estate (CE)

Vontobel Financial Produ...

MTL Cannabis (QB)

Intesa Sanpaolo

BNP Paribas Issuance

Delayed Upgrade Clock

도움 및 지원받기: kr-support@advfn.com

ADVFN 서비스 이용은 ADVFN의 이용약관에 동의하는 것입니다 이용약관